IP Library Granted Patent US 8,672,932
Granted Patent B2
US 8,672,932 · App. 11/728,457 · Granted Mar 18, 2014

Center fed dipole for use with tissue ablation systems, devices and methods

Inventors: Daniel W. van der Weide (Madison, WI); Fred T. Lee, Jr. (Madison, WI); Paul F. Laeseke (Madison, WI); Christopher L. Brace (Madison, WI)
Assignee: Neuwave Medical, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,672,932
App. No.
11/728,457
Granted
Mar 18, 2014
Kind
B2
Abstract

The present invention relates to systems and devices for delivering energy to tissue for a wide variety of applications, including medical procedures (e.g., tissue ablation, resection, cautery, vascular thrombosis, treatment of cardiac arrhythmias and dysrhythmias, electrosurgery, tissue harvest, etc.). In particular, the present invention relates to systems and devices for the delivery of energy employing a center fed dipole component. In certain embodiments, methods are provided for treating a tissue region (e.g., a tumor) through application of energy with the systems and devices of the present invention.

Claims (26)

1. A device comprising an antenna configured for delivery of energy to a tissue, wherein a distal end of said antenna comprises a center-fed dipole component comprising a rigid hollow tube encompassing a conductor, wherein said conductor has a proximal end and a distal end, wherein said distal end of said conductor engages said rigid hollow tube via connection with the center of a conductive material that spans across said rigid hollow tube thereby preventing said distal end of said conductor from contact with said rigid hollow tube, wherein said distal end of said conductor does not extend beyond said conductive material thereby preventing said conductor from contact with said tissue, wherein said hollow tube has a diameter equal to or less than a 16-gauge needle, wherein said energy is microwave energy.

2. The device of claim 1 , wherein said hollow tube has a diameter equal to or less than a 20-gauge needle.

3. The device of claim 1 , wherein said hollow tube has a diameter equal to or less than a 17-gauge needle.

4. The device of claim 1 , further comprising a tuning element for adjusting the amount of energy delivered to said tissue.

5. The device of claim 1 , wherein said device is configured to deliver a sufficient amount of energy to ablate said tissue or cause thrombosis.

6. The device of claim 1 , wherein said conductor extends halfway through said hollow tube.

7. The device of claim 1 , wherein said hollow tube has a length of approximately λ/2, wherein λ is the electromagnetic field wavelength in the medium of the tissue to resonate within the medium, such that a minimum of power reflection at the proximal end is provided.

8. A system for ablation therapy, comprising a power distributor and a device comprising an antenna configured for delivery of energy to a tissue, wherein a distal end of said antenna comprises a center-fed dipole component comprising a rigid hollow tube encompassing a conductor, wherein said conductor has a proximal end and a distal end, wherein said distal end of said conductor engages said rigid hollow tube via connection with the center of a conductive material that spans across said rigid hollow tube thereby preventing said distal end of said conductor from contact with said rigid hollow tube, wherein said distal end of said conductor does not extend beyond said conductive material thereby preventing said conductor from contact with said tissue, said hollow tube has a diameter equal to or less than a 16-gauge needle, wherein said energy is microwave energy.

9. The device of claim 8 , wherein said hollow tube has a diameter equal to or less than a 20-gauge needle.

10. The system of claim 8 , wherein said hollow tube has a diameter equal to or less than a 17-gauge needle.

11. The system of claim 8 , further comprising a tuning element for adjusting the amount of energy delivered to said tissue.

12. The system of claim 8 , wherein said device is configured to deliver a sufficient amount of energy to ablate said tissue or cause thrombosis.

13. The system of claim 8 , wherein said inner conductor extends halfway through said hollow tube.

14. The device of claim 8 , wherein said hollow tube has a length λ/2, wherein λ is the electromagnetic field wavelength in the medium of the tissue to resonate within the medium, such that a minimum of power reflection at the proximal end is provided.

15. The system of claim 8 , further comprising a generator.

16. A method of treating a tissue region, comprising:

a) providing a tissue region and a device comprising an antenna configured for delivery of energy to a tissue, wherein a distal end of said antenna comprises a center-fed dipole component comprising a rigid hollow tube encompassing a conductor, wherein said conductor has a proximal end and a distal end, wherein said distal end of said conductor engages said rigid hollow tube via connection with the center of a conductive material that spans across said rigid hollow tube thereby preventing said distal end of said conductor from contact with said rigid hollow tube, wherein said distal end of said conductor does not extend beyond said conductive material thereby preventing said conductor from contact with said tissue, wherein said hollow tube has a diameter equal to or less than a 16 -gauge needle, wherein said energy is microwave energy;

b) positioning said device in the vicinity of said tissue region,

c) delivering an amount of energy with said device to said tissue region.

17. The method of claim 16 , wherein said tissue region is a tumor.

18. The device of claim 16 , wherein said hollow tube has a diameter equal to or less than a 20-gauge needle.

19. The method of claim 16 , wherein said hollow tube has a diameter equal to or less than a 17-gauge needle.

20. The method of claim 16 , further providing a tuning element for adjusting the amount of energy delivered to said tissue region.

21. The method of claim 16 , wherein said device is configured to deliver a sufficient amount of energy to ablate said tissue region or cause thrombosis.

22. The method of claim 16 , wherein said inner conductor extends halfway through said hollow tube.

23. The method of claim 16 , wherein said hollow tube has a length of approximately λ/2, wherein λ is the electromagnetic field wavelength in the medium of the tissue to resonate within the medium, such that a minimum of power reflection at the proximal end is provided.

Assignments (6)
RELEASE Recorded Dec 4, 2015
From: SILICON VALLEY BANK
To: NEUWAVE MEDICAL, INC.
Reel/Frame 037301/0939 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE'S NAME ON ASSIGNMENT FROM "MICRABLATE, INC." TO "MICRABLATE, LLC" PREVIOUSLY RECORDED ON REEL 020816 FRAME 0969. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 8, 2012
From: VAN DER WEIDE, DANIEL WARREN; LAESEKE, PAUL F.; LEE, FRED T., JR.; BRACE, CHRISTOPHER L.
To: MICRABLATE, LLC
Reel/Frame 028748/0509 →
SECURITY AGREEMENT Recorded May 24, 2012
From: NEUWAVE MEDICAL, INC.
To: SILICON VALLEY BANK
Reel/Frame 028275/0079 →
CONVERSION Recorded May 28, 2008
From: MICRABLATE, LLC
To: NEUWAVE THERAPY, INC.
Reel/Frame 021006/0051 →
CHANGE OF NAME Recorded May 28, 2008
From: NEUWAVE THERAPY, INC.
To: NEUWAVE MEDICAL, INC.
Reel/Frame 021006/0072 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 17, 2008
From: VAN DER WEIDE, DANIEL WARREN; LAESEKE, PAUL F.; LEE, FRED T., JR.; BRACE, CHRISTOPHER L.
To: MICRABLATE, INC.
Reel/Frame 020816/0969 →
Continuity (2)
Provisional Application 60785690 · Mar 24, 2006
Related Publication 20070282319A1 · Dec 6, 2007